SSGSX
Price
$53.51
Change
-$0.19 (-0.35%)
Updated
Jul 2 closing price
Net Assets
4.64B
VSCVX
Price
$37.63
Change
+$0.03 (+0.08%)
Updated
Jul 2 closing price
Net Assets
1.15B
Interact to see
Advertisement

SSGSX vs VSCVX

SSGSX vs VSCVX Comparison Chart in %
View a ticker or compare two or three
VS
SSGSX vs. VSCVX commentary
Jul 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SSGSX is a StrongBuy and VSCVX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SSGSX has more cash in the bank: 4.64B vs. VSCVX (1.15B). VSCVX pays higher dividends than SSGSX: VSCVX (0.55) vs SSGSX (0.51). SSGSX was incepted earlier than VSCVX: SSGSX (27 years) vs VSCVX (22 years). VSCVX (1.43) is less costly to investors than SSGSX (1.23). SSGSX is a more actively managed with annual turnover of: 50.00 vs. VSCVX (44.00). SSGSX (6%) and VSCVX (6%) have equivalent initial investment costs. SSGSX (2500) and VSCVX (2500) have matching initial minimum investment requirements. VSCVX annual gain was more profitable for investors over the last year : 33.94 vs. SSGSX (19.16). SSGSX return over 5 years is better than : -1.36 vs. VSCVX (-11.40).
SSGSXVSCVXSSGSX / VSCVX
Total Expense Ratio1.231.4386%
Annual Report Gross Expense Ratio1.231.4386%
Fund Existence27 years22 years-
Gain YTD19.73623.49984%
Front Load6%6%100%
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets4.64B1.15B404%
Annual Yield % from dividends0.510.5594%
Returns for 1 year19.1633.9456%
Returns for 3 years14.3516.4287%
Returns for 5 years-1.36-11.4012%
Returns for 10 years47.2526.48178%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NSIVX12.990.26
+2.04%
North Square Altrinsic Intl Eq I
WMKGX24.810.04
+0.16%
WesMark Large Company Fund
MFOCX30.36-0.03
-0.10%
Marsico Focus
BMSYX17.48-0.10
-0.57%
MFS Blended Research Mid Cap Eq R6
JGTUX42.85-0.76
-1.74%
JPMorgan Growth Advantage R4